News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,511 Results
Type
Article (24130)
Company Profile (131)
Press Release (361243)
Multimedia
Podcasts (48)
Webinars (17)
Section
Business (121192)
Career Advice (1451)
Deals (20473)
Drug Delivery (86)
Drug Development (34365)
Employer Resources (157)
FDA (6494)
Job Trends (8666)
News (183715)
Policy (13564)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1688)
Academic (2)
Accelerated approval (26)
Adcomms (18)
Allergies (60)
Alliances (27399)
ALS (107)
Alzheimer's disease (950)
Antibody-drug conjugate (ADC) (217)
Approvals (6750)
Artificial intelligence (426)
Autoimmune disease (157)
Automation (37)
Bankruptcy (133)
Best Places to Work (6727)
BIOSECURE Act (12)
Biosimilars (109)
Biotechnology (78)
Bladder cancer (92)
Brain cancer (32)
Breast cancer (332)
Cancer (2575)
Cardiovascular disease (250)
Career advice (1262)
Career pathing (46)
CAR-T (179)
CDC (33)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (20)
Clinical research (29605)
Collaboration (1216)
Company closure (1)
Compensation (584)
Complete response letters (31)
COVID-19 (1265)
CRISPR (68)
C-suite (907)
Cystic fibrosis (79)
Data (3918)
Decentralized trials (2)
Denatured (30)
Depression (77)
Dermatology (52)
Diabetes (254)
Diagnostics (3947)
Digital health (32)
Diversity (11)
Diversity, equity & inclusion (43)
Drug discovery (205)
Drug pricing (84)
Drug shortages (10)
Duchenne muscular dystrophy (138)
Earnings (51375)
Editorial (34)
Employer branding (23)
Employer resources (137)
Events (62602)
Executive appointments (851)
FDA (8248)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (11)
Frontotemporal dementia (20)
Funding (1109)
Gene editing (127)
Generative AI (37)
Gene therapy (329)
GLP-1 (512)
Government (1801)
Guidances (269)
Healthcare (8959)
HIV (56)
Huntington's disease (29)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (43)
Immunology and inflammation (103)
Immuno-oncology (36)
Indications (88)
Infectious disease (1441)
Inflammatory bowel disease (118)
Inflation Reduction Act (8)
Influenza (62)
Intellectual property (103)
Interviews (211)
IPO (9938)
IRA (22)
Job creations (2109)
Job search strategy (1069)
JPM (29)
Kidney cancer (14)
Labor market (97)
Layoffs (292)
Leadership (29)
Legal (3331)
Liver cancer (45)
Longevity (20)
Lung cancer (312)
Lymphoma (225)
Machine learning (34)
Management (48)
Manufacturing (547)
MASH (95)
Medical device (5978)
Medtech (6035)
Mergers & acquisitions (11349)
Metabolic disorders (659)
mRNA (89)
Multiple sclerosis (108)
NASH (14)
Neurodegenerative disease (209)
Neuropsychiatric disorders (41)
Neuroscience (1740)
Neurotech (1)
NextGen: Class of 2026 (3334)
Non-profit (2226)
Now hiring (78)
Obesity (301)
Opinion (183)
Ovarian cancer (85)
Pain (116)
Pancreatic cancer (115)
Parkinson's disease (181)
Partnered (23)
Patents (175)
Patient recruitment (274)
Peanut (23)
People (41932)
Pharmaceutical (30)
Pharmacy benefit managers (5)
Phase 1 (8719)
Phase 2 (12506)
Phase 3 (11008)
Pipeline (5149)
Policy (149)
Postmarket research (1075)
Preclinical (4129)
Press Release (71)
Prostate cancer (141)
Psychedelics (30)
Radiopharmaceuticals (178)
Rare diseases (523)
Real estate (3708)
Recruiting (63)
Regulatory (10783)
Reports (59)
Research institute (1485)
Resumes & cover letters (223)
Rett syndrome (26)
RNA editing (11)
RSV (55)
Schizophrenia (111)
Series A (194)
Series B (143)
Service/supplier (7)
Sickle cell disease (58)
Special edition (13)
Spinal muscular atrophy (86)
Sponsored (22)
Startups (2517)
State (1)
Stomach cancer (7)
Supply chain (57)
Tariffs (29)
The Weekly (18)
Vaccines (442)
Venture capital (87)
Weight loss (171)
Women's health (68)
Worklife (20)
Date
Last 7 days (321)
Last 30 days (1698)
Last 365 days (16228)
2026 (7467)
2025 (16279)
2024 (19323)
2023 (22384)
2022 (29040)
2021 (31549)
2020 (29511)
2019 (24433)
2018 (18173)
2017 (17530)
2016 (16860)
2015 (20002)
2014 (15564)
2013 (12751)
2012 (13740)
2011 (14335)
2010 (13852)
Location
Africa (485)
Alabama (44)
Alaska (5)
Arizona (165)
Arkansas (5)
Asia (20676)
Australia (3353)
California (7133)
Canada (2225)
China (530)
Colorado (312)
Connecticut (351)
Delaware (259)
Europe (49006)
Florida (1064)
Georgia (191)
Hawaii (3)
Idaho (31)
Illinois (450)
India (59)
Indiana (426)
Iowa (20)
Japan (351)
Kansas (67)
Kentucky (28)
Louisiana (18)
Maine (62)
Maryland (687)
Massachusetts (5605)
Michigan (211)
Minnesota (353)
Mississippi (5)
Missouri (79)
Montana (20)
Nebraska (20)
Nevada (76)
New Hampshire (29)
New Jersey (2074)
New Mexico (21)
New York (2021)
North Carolina (1064)
North Dakota (10)
Northern California (3761)
Ohio (243)
Oklahoma (14)
Oregon (21)
Pennsylvania (1245)
Puerto Rico (11)
Rhode Island (30)
South America (627)
South Carolina (30)
Southern California (2641)
Tennessee (131)
Texas (1034)
United States (25701)
Utah (197)
Vermont (1)
Virginia (188)
Washington D.C. (47)
Washington State (588)
West Virginia (3)
Wisconsin (118)
Wyoming (1)
385,511 Results for "exact sciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abbott completes acquisition of Exact Sciences
March 23, 2026
·
4 min read
Press Releases
Abbott acquisition of Exact Sciences set to close on March 23, 2026
March 20, 2026
·
5 min read
Press Releases
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
April 16, 2026
·
18 min read
Press Releases
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
March 4, 2026
·
2 min read
Press Releases
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
February 15, 2026
·
19 min read
Press Releases
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
March 18, 2026
·
4 min read
Press Releases
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
February 9, 2026
·
3 min read
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
Press Releases
Exact Sciences Announces Third Quarter 2025 Results
November 3, 2025
·
19 min read
Press Releases
Exact Sciences to Participate in November 2025 Investor Conference
November 5, 2025
·
1 min read
1 of 38,552
Next
